-
MODELLING HETEROGENEITY WITHOUT INDIVIDUAL SIMULATION: STRUCTURAL CHOICES AND SAMPLING STRATEGIES
Mar 18, 2026, 21:06 PM -
COMPARING METHODOLOGICAL AND REPORTING STANDARDS FOR HEALTH ECONOMIC EVALUATION: INSIGHTS FROM NICE TSD 15, ISPOR GOOD PRACTICES, AND CHEERS 2022 GUIDELINES
Mar 18, 2026, 21:06 PM -
GROWTH IN PRIVATE-PAYER MARKUPS FOR INFUSED CHEMOTHERAPY RELATIVE TO MEDICARE AVERAGE SALES PRICE BY SITE OF CARE, 2015-2023
Mar 18, 2026, 21:02 PM -
SETTING EVIDENCE STANDARDS BEFORE SETTING INTERNATIONAL PRICE BENCHMARKS: INSIGHTS FROM EX-U.S. G7 HEALTH TECHNOLOGY ASSESSMENTS ON TOP-SPENDING U.S. MEDICARE PART B BIOLOGICS
Mar 18, 2026, 21:02 PM -
INTERNATIONAL AVAILABILITY AND PRICE OF ULTRA-EXPENSIVE DRUGS IN MEDICARE PART D: ASSESSING THE FEASIBILITY OF EXTERNAL REFERENCE PRICING
Mar 18, 2026, 21:02 PM -
PROJECTED MEDICARE DRUG PRICE NEGOTIATION SAVINGS IN 2027
Mar 18, 2026, 21:02 PM -
DISPARITY CONSIDERATIONS IN AN ALTERNATIVE ELIGIBILITY CRITERION FOR MEDICARE MEDICATION THERAPY MANAGEMENT PROGRAMS WITH MACHINE LEARNING
Mar 18, 2026, 21:00 PM -
NOT JUST GLP-1 COSTS: WHY LOWER DIABETES DRUG EXPENDITURES MAY NOT REFLECT BETTER CARE
Mar 18, 2026, 21:00 PM -
MAPPING ACCESS DESERTS: A GEOSPATIAL ASSESSMENT OF SOCIOECONOMIC DISPARITIES IN THE UNITED STATES DLBCL CAR-T THERAPY NETWORK
Mar 18, 2026, 21:00 PM -
MATERIAL HARDSHIP AND MULTI-CANCER SCREENING ADHERENCE: IMPLICATIONS BEYOND INSURANCE STATUS
Mar 18, 2026, 21:00 PM -
WHAT DOES A “SOCIETAL PERSPECTIVE” INCLUDE IN PRACTICE? A SYSTEMATIC ANALYSIS OF ICER ASSESSMENTS IN ULTRA-RARE DISEASES
Mar 18, 2026, 20:59 PM -
A BREATHTAKING GAP IN THE SOCIAL COST OF CARBON: VALUING HEALTH LOSSES FROM CLIMATE CHANGE
Mar 18, 2026, 20:59 PM -
APPETITE DYSREGULATION AND BODY MASS INDEX AMONG ADULTS WITH DEPRESSION AND ANXIETY IN THE REAL-WORLD SETTING
Mar 18, 2026, 20:58 PM -
RACIAL AND ETHNIC DIFFERENCES IN DEMAND FOR NOVEL DEMENTIA THERAPIES: EVIDENCE FROM A NATIONAL SURVEY OF OLDER ADULTS' PREFERENCES ACROSS DEMENTIA DRUG ATTRIBUTES
Mar 18, 2026, 20:58 PM -
DEVELOPING AND VALIDATING A CULTURALLY-ADAPTED OPTIMAL SHORT-FORM OF THE EDINBURGH POSTNATAL DEPRESSION SCALE (EPDS) USING RISKSLIM
Mar 18, 2026, 20:58 PM -
HOSPITAL CLINICAL DATA NETWORK AND RESEARCH ORGANIZATION COLLABORATION FOR ANALYSIS OF INFECTION BURDEN IN IMMUNOCOMPROMISED PATIENTS IN FRANCE USING REAL-WORLD ELECTRONIC MEDICAL RECORD DATA
Mar 18, 2026, 20:57 PM -
TRANSPORTABILITY-INFORMED CLINICAL AND ECONOMIC EVALUATION OF TIRZEPATIDE FOR LOCAL HTA DECISION-MAKING
Mar 18, 2026, 20:57 PM -
VIRTUAL POOLING IS ACCURATE AND LIGHTWEIGHT FOR MULTI-INSTITUTION CAUSAL INFERENCE WITHOUT CENTRALIZED DATA SHARING
Mar 18, 2026, 20:57 PM -
POST-MARKETING PHARMACOVIGILANCE ANALYSIS OF UBLITUXIMAB USING FAERS DATABASE AND LITERATURE MINING
Mar 18, 2026, 20:57 PM -
REAL-WORLD COMPARATIVE EFFECTIVENESS OF SEMAGLUTIDE 2.4 MG VERSUS OTHER COMMERCIALLY AVAILABLE MEDICATIONS FOR CHRONIC WEIGHT MANAGEMENT IN ADULTS WITH OBESITY IN THE UNITED STATES: A PRAGMATIC CLINICAL STUDY
Mar 18, 2026, 20:55 PM
